INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 1982

Nicotinamide inhibited the metabolism of primidone and increased carbamazepine levels in humans.

The effect of nicotinamide on the conversion of primidone to phenobarbital was examined in mice and three epileptic patients. In mice, 200 mg/kg of nicotinamide increased primidone's half-life by 47.6% and decreased conversion to phenobarbital and phenylethylmalonamide by 32.4% and 14.5%, respectively. In patients, nicotinamide decreased the conversion of primidone to phenobarbital, with dose correlating directly with the primidone-phenobarbital ratio (r = 0.861, p < 0.01). Nicotinamide also increased carbamazepine levels in two patients.

Study type
Intervention study / case series and animal study
Who was studied
3 epileptic patients (and 2 treated with carbamazepine), plus mice
What was measured
Primidone conversion to phenobarbital, carbamazepine levels

THE PAPER

Interactions between primidone, carbamazepine, and nicotinamide.

Bourgeois BF, Dodson WE, Ferrendelli JA. Neurology, 1982.

PubMed 6214728 ↗DOI 10.1212/wnl.32.10.1122 ↗

Nutrients & adequacyBrain & mood

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.